Astrana Health (ASTH) Operating Leases (2019 - 2026)

Astrana Health (ASTH) has 8 years of Operating Leases data on file, last reported at $30.0 million in Q1 2026.

• Quarterly Operating Leases rose 3.6% year-over-year to $30.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.0 million (up 3.6% YoY) and the FY2025 annual result came in at $31.6 million, up 2.93% from the prior year.
• Operating Leases fell to $30.0 million in Q1 2026 per ASTH's latest filing, from $31.6 million in the prior quarter.
• The five-year high for Operating Leases was $42.7 million in Q1 2024, with the low at $15.2 million in Q1 2022.
• Average Operating Leases over 5 years is $26.8 million, with a median of $28.7 million recorded in 2025.
• Year-over-year, Operating Leases soared 135.21% in 2024 and sank 32.21% in 2025.
• Astrana Health's Operating Leases stood at $19.9 million in 2022, then soared by 82.22% to $36.3 million in 2023, then declined by 15.53% to $30.7 million in 2024, then gained by 2.93% to $31.6 million in 2025, then fell by 4.9% to $30.0 million in 2026.
• Business Quant data shows ASTH's Operating Leases at $30.0 million in Q1 2026, $31.6 million in Q4 2025, and $30.2 million in Q3 2025.